Bicyclic antagonists selective for the alphavbeta3 integrin
申请人:Wyeth
公开号:US20030109523A1
公开(公告)日:2003-06-12
This invention provides novel bicyclic compounds of Formula (I):
1
wherein u, v, m, Y, G, A-B, R
1
, R
1a
, R
2
, R
4
, R
5
, R
5a
, and R
5b
are defined in the specification which compounds exhibit activity as inhibitors of bone resorption and compounds of Formula (II)
2
wherein u, v, m, Y, G, D, A-B, R
1
, R
1a
, R
2
, R
3
R
4
, R
5
, R
5a
, and R
5b
are defined in the specification which compounds exhibit activity as inhibitors of bone resorption.